Effectiveness and safety of reference infliximab and biosimilar in ulcerative colitis: a French real-life equivalence study

(1) Caisse Nationale Assurance Maladie,St-Denis,France

(2) Hôtel Dieu, AP-HP,Paris,France

(3) CHU Bicetre,Le Kremlin Bicetre,France



This item was part of the IBD I (Posters) session at UEG Week 2019

This item can be cited as: United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019